August 2024 | Report Format: Electronic (PDF)
Sacroiliac Joint Fusion Surgery Market Growth & Trends
The global sacroiliac joint fusion surgery market size is expected to reach USD 984.9 million by 2030, registering a CAGR of 19.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing product launches and approvals are driving market growth. In March 2023, CoreLink Surgical received 510(k) clearance from the U.S. FDA for its Siber Ti Sacroiliac Joint Fusion System, which encompasses a diverse range of fully porous, nano-surfaced, 3D-printed implants in its portfolio. Similarly, in March 2022, Life Spine, Inc. received FDA clearance for marketing its SImpact SI Joint Fixation System for posterior-oblique approaches.
Sacroiliitis is often used interchangeably with SI joint dysfunction, specifically the pain arising from the SI joint. The increasing number of SI cases is a pivotal factor contributing to the increasing adoption of diverse treatment options, propelling the market growth. According to Wolters Kluwer Health, Inc. data, as of April 2020, approximately 33.3% of the global population is afflicted by SI joint dysfunction. Furthermore, this source highlights that lumbar pain is prevalent in 50% to 80% of cases, contributing to SI joint dysfunction. Clinical assessments reveal that approximately 15% to 30% of individuals experiencing lumbar pain also concurrently suffer from SI joint dysfunction. Consequently, the increasing prevalence of sacroiliitis or SI joint dysfunction is poised to be a significant factor driving SI joint fusion surgery market growth.
The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing product formation and reach. In addition, the players are securing funding from government and non-government bodies to develop advanced treatment. For instance, in September 2023, PainTEQ introduced its latest surgery-ready instrument set, which represents a significant progression in the field of SI joint fusion surgery. This set of surgical instruments for PainTEQ’s LinQ procedure comprises surgery-ready, single-use instruments, providing interventional pain physicians with a safer and more economical alternative.
The growing adoption of surgeries for the treatment of sacroiliac joint pain is fostering market growth. Furthermore, the increasing availability of reimbursement coverage for healthcare expenses bolsters the affordability and accessibility of these treatments. Increasing funding and government support are further accelerating market growth. The increasing prevalence of lower back, buttock, groin, and lower extremity pain is driving the market growth.
Request a free sample copy or view report summary:
Sacroiliac Joint Fusion Surgery Market Report
Sacroiliac Joint Fusion Surgery Market Report Highlights
- Based on indication, the degenerative sacroiliitis segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of degenerative sacroiliitis.
- Based on type, the minimally invasive surgery (MIS) segment is anticipated to grow at the fastest CAGR over the forecast period in the market owing to a rising preference for MIS.
- Based on approach, the dorsal & anterior segment is anticipated to grow at the fastest CAGR over the forecast period. This is due to the advantages associated with this approach, which include direct curettage and bone grafting into the sacroiliac joint area, resulting in good bone union.
- Based on product, the implants segment is anticipated to grow at the fastest CAGR over the forecast period in the market owing to rising advancements in technology & materials.
- Based on end use, the hospitals segment held the largest revenue share in the market in 2023 owing to the increasing preference of patients and the increased number of surgeries conducted within hospital settings.
- North America dominated the market due to the presence of key industry leaders in the region. In addition, the region’s advanced healthcare infrastructure, coupled with the increasing availability of reimbursement coverage, is driving market growth.
Sacroiliac Joint Fusion Surgery Market Segmentation
Grand View Research has segmented the global sacroiliac joint fusion surgery market based on type, indication, approach, product application, end use, and region:
Sacroiliac Joint Fusion Surgery Type Outlook (Revenue, USD Million, 2018–2030)
- MIS
- Open
Sacroiliac Joint Fusion Surgery Indication Outlook (Revenue, USD Million, 2018–2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
Sacroiliac Joint Fusion Surgery Approach Outlook (Revenue, USD Million, 2018–2030)
- Dorsal & anterior
- Lateral
Sacroiliac Joint Fusion Surgery Product Outlook (Revenue, USD Million, 2018–2030)
- Implants
- Accessories
Sacroiliac Joint Fusion Surgery End Use Outlook (Revenue, USD Million, 2018–2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
Sacroiliac Joint Fusion Surgery Regional Outlook (Revenue, USD Million, 2018–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in the Sacroiliac Joint Fusion Surgery Market
- SI-BONE, Inc.
- CornerLoc
- Globus Medical
- Orthofix Medical, Inc.
- Camber Spine Technologies, LLC
- Life Spine, Inc.
- CoreLink Surgical
- PainTEQ
- SIGNUS Medizintechnik GmbH
- Medtronic
